Trandate



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 55.6%
Hypertension 22.2%
Blood Pressure 11.1%
Hyperphosphataemia 11.1%
Inappropriate Schedule Of Drug Administration 16.7%
Nodal Arrhythmia 16.7%
Renal Artery Stenosis 16.7%
Renal Failure 16.7%
Supraventricular Extrasystoles 16.7%
Vomiting 16.7%
Secondary
Hypertension 18.5%
Product Used For Unknown Indication 15.0%
Essential Hypertension 14.0%
Drug Use For Unknown Indication 7.1%
Drug Exposure During Pregnancy 4.5%
Epilepsy 4.5%
Neuropsychiatric Lupus 4.2%
Pre-eclampsia 4.2%
Hypotension 3.4%
Diabetes Mellitus 3.2%
Complication Of Pregnancy 2.6%
Hypothyroidism 2.6%
Osteoporosis 2.4%
Type 2 Diabetes Mellitus 2.4%
Depression 2.1%
Prophylaxis 2.1%
Systemic Lupus Erythematosus 2.1%
Prostatitis 1.8%
Cardiac Failure 1.6%
Gastritis 1.6%
Premature Baby 18.2%
Thrombocytopenia 7.8%
Bone Marrow Failure 6.5%
Bone Marrow Toxicity 5.2%
Foetal Growth Restriction 5.2%
Renal Failure 5.2%
Respiratory Distress 5.2%
Sudden Death 5.2%
Intra-uterine Death 3.9%
Lactic Acidosis 3.9%
Leukocytoclastic Vasculitis 3.9%
Pierre Robin Syndrome 3.9%
Premature Labour 3.9%
Tinnitus 3.9%
Tracheomalacia 3.9%
Tremor 3.9%
Drug Exposure Via Breast Milk 2.6%
Hypertension 2.6%
Maternal Drugs Affecting Foetus 2.6%
Maternal Exposure Timing Unspecified 2.6%
Concomitant
Product Used For Unknown Indication 32.1%
Drug Use For Unknown Indication 22.2%
Hypertension 17.2%
Pain 3.7%
Diabetes Mellitus 2.9%
Depression 2.6%
Nuclear Magnetic Resonance Imaging 2.6%
Rheumatoid Arthritis 1.9%
Angiogram 1.6%
Atrial Fibrillation 1.6%
Insomnia 1.4%
Prophylaxis 1.4%
Drug Exposure During Pregnancy 1.3%
Multiple Sclerosis 1.3%
Renal Transplant 1.3%
Foetal Exposure During Pregnancy 1.1%
Sepsis 1.1%
Hiv Infection 0.9%
Multiple Myeloma 0.9%
Nausea 0.9%
Premature Baby 17.8%
Weight Decreased 7.8%
Dermatitis Bullous 5.6%
Myocardial Infarction 5.6%
Umbilical Cord Abnormality 5.6%
Blood Pressure Increased 4.4%
Colon Cancer Stage Iii 4.4%
Intra-uterine Death 4.4%
Rash 4.4%
Tongue Neoplasm Malignant Stage Unspecified 4.4%
Toxic Skin Eruption 4.4%
Withdrawal Syndrome 4.4%
Hypertension 3.3%
Oedema Peripheral 3.3%
Paraesthesia 3.3%
Pre-eclampsia 3.3%
Pulmonary Arterial Hypertension 3.3%
Transient Ischaemic Attack 3.3%
Unresponsive To Stimuli 3.3%
Venous Stenosis 3.3%